학술논문

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
Document Type
Article
Author
Sacks-Davis, Rachelvan Santen, Daniela KBoyd, AndersYoung, JimStewart, AshleighDoyle, Joseph SRauch, AndriMugglin, CatrinaKlein, Marinavan der Valk, MarcSmit, ColetteJarrin, InmaculadaBerenguer, JuanLacombe, KarineRequena, Maria-BernardaWittkop, LindaLeleux, OlivierBonnet, FabriceSalmon, DominiqueMatthews, Gail VGuy, RebeccaMartin, Natasha KSpelman, TimPrins, MariaStoove, MarkHellard, MargaretHellard, Margaret ESacks-Davis, Rachelvan Santen, Daniela KStewart, AshleighKe, TianhuiZhang, YanqinStoove, MarkGuy, RebeccaPedrana, AlisaAsselin, JasonDawe, JoshuaWilkinson, AnnaBoyd, AndersSmit, Colettevan der Valk, MarcSchinkel, JankeWittkop, LindaSalmon, DominiqueSogni, PhilippeEsterle, LaureGilbert, CamilleMerchadou, LaurenceGillet, StephanieKhan, CoralieBonnet, FabriceLeleux, OlivierLe Marec, FabienPerrier, AdelaideMatthews, GailShaw, InekeMartinello, MarianneApplegate, TanyaCarson, JoanneDoyle, Joseph SHarney, BrendanBryant, MelissaJarrin Vera, InmaculadaBerenguer, JuanAlejos, BelenLazarus, Jeffrey VMoreno, CristinaIzquierdo, RebeccaRava, MartaKlein, MarinaWang, ShouaoLumia, JessicaPexos, CostaPeiris, HansiSaeed, SaharMoodie, EricaYoung, JimPick, NeoraConway, BrianHull, MarkWong, AlexGill, JohnBarrett, LisaCohen, JeffCox, JosephCote, PierreHaider, ShariqRouleau, DanielleVachon, Marie-LouiseRachlis, AnitaSandre, RogerWalmsley, SharonSadr, AidaCooper, CurtisSanche, SteveRauch, AndriMugglin, CatrinaSalazar-Viscaya, LuisaKusejko, KatharinaPrins, MariaHage, KrisLacombe, KarineRequena, Maria-BernadaGirard, Pierre-MarieBrucker, MatthieuVincensini, Jean-Paul
Source
The Lancet HIV; February 2024, Vol. 11 Issue: 2 pe106-e116, 11p
Subject
Language
ISSN
24054704; 23523018
Abstract
Reinfection after successful treatment with direct-acting antivirals is hypothesised to undermine efforts to eliminate hepatitis C virus (HCV) infection among people with HIV. We aimed to assess changes in incidence of HCV reinfection among people with HIV following the introduction of direct-acting antivirals, and the proportion of all incident cases attributable to reinfection.